{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:23:53Z","timestamp":1774124633165,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"DOI":"10.1097\/qai.0b013e31818ce6c4","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T08:40:27Z","timestamp":1229416827000},"page":"37-43","source":"Crossref","is-referenced-by-count":58,"title":["Successful Integration of Tuberculosis and HIV Treatment in Rural South Africa: The Sizonq'oba Study"],"prefix":"10.1097","volume":"50","author":[{"given":"Neel R","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony P","family":"Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh","family":"Lalloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Pawinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravi","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-5-20210131","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/501018","article-title":"Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions.","volume":"42","author":"Lawn","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R4-5-20210131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00002030-200101260-00002","article-title":"Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa.","volume":"15","author":"Mukadi","year":"2001","journal-title":"AIDS"},{"key":"R5-5-20210131","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/00002030-199908200-00015","article-title":"Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa.","volume":"13","author":"Connolly","year":"1999","journal-title":"AIDS"},{"key":"R6-5-20210131","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/ajrccm.159.3.9804147","article-title":"Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.","volume":"159","author":"Murray","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-5-20210131","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","article-title":"Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"issue":"Suppl 5","key":"R8-5-20210131","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/421407","article-title":"Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.","volume":"38","author":"Friedland","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R9-5-20210131","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1473-3099(06)70549-7","article-title":"Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis\/HIV collaboration.","volume":"6","author":"Reid","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R10-5-20210131","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00002030-200404300-00004","article-title":"Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care.","volume":"18","author":"Abdool-Karim","year":"2004","journal-title":"AIDS"},{"issue":"Suppl 1","key":"R12-5-20210131","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/518660","article-title":"Tuberculosis and HIV infection: the global setting.","volume":"196","author":"Nunn","year":"2007","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"R13-5-20210131","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/518664","article-title":"Implementation issues in tuberculosis\/HIV program collaboration and integration: 3 case studies.","volume":"196","author":"Friedland","year":"2007","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"R14-5-20210131","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1086\/518655","article-title":"Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.","volume":"196","author":"McIlleron","year":"2007","journal-title":"J Infect Dis"},{"key":"R15-5-20210131","first-page":"62","article-title":"Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics.","volume":"9","author":"Tsiouris","year":"2007","journal-title":"Medscape Gen Med"},{"key":"R16-5-20210131","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/00126334-200408010-00006","article-title":"A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting.","volume":"36","author":"Jack","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-5-20210131","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"R20-5-20210131","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/339074","article-title":"The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.","volume":"34","author":"Mannheimer","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R24-5-20210131","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1086\/424676","article-title":"Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.","volume":"190","author":"Dheda","year":"2004","journal-title":"J Infect Dis"},{"key":"R25-5-20210131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"R26-5-20210131","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(08)60345-1","article-title":"Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study.","volume":"371","author":"Mermin","year":"2008","journal-title":"Lancet"},{"key":"R27-5-20210131","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3201\/eid1307.061506","article-title":"Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.","volume":"13","author":"Akksilp","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R28-5-20210131","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/374602","article-title":"Once-a-day highly active antiretroviral therapy: a systematic review.","volume":"36","author":"Ena","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R29-5-20210131","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00002030-200305020-00010","article-title":"Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal.","volume":"17","author":"Landman","year":"2003","journal-title":"AIDS"},{"key":"R30-5-20210131","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/dkl357","article-title":"Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.","volume":"58","author":"Lopez-Cortes","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R31-5-20210131","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/01.aids.0000183630.27665.30","article-title":"Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin.","volume":"19","author":"Manosuthi","year":"2005","journal-title":"AIDS"},{"key":"R32-5-20210131","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jac\/dkl399","article-title":"Administration of efavirenz (600 mg\/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV.","volume":"58","author":"Friedland","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R33-5-20210131","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"R34-5-20210131","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1086\/518658","article-title":"Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials.","volume":"196","author":"Blanc","year":"2007","journal-title":"J Infect Dis"},{"key":"R35-5-20210131","doi-asserted-by":"crossref","first-page":"S449","DOI":"10.1086\/521112","article-title":"Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary.","volume":"196","author":"Murphy","year":"2007","journal-title":"J Infect Dis"},{"key":"R38-5-20210131","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/522987","article-title":"Evolution of the extensively drug-resistant F15\/LAM4\/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.","volume":"45","author":"Pillay","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R39-5-20210131","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid1303.061400","article-title":"Worldwide emergence of extensively drug-resistant tuberculosis (XDR-TB).","volume":"13","author":"Shah","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 1","key":"R40-5-20210131","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1086\/518661","article-title":"Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment.","volume":"196","author":"Bock","year":"2007","journal-title":"J Infect Dis"},{"key":"R41-5-20210131","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"R42-5-20210131","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1371\/journal.pmed.0040068","article-title":"Natural ventilation for the prevention of airborne contagion.","volume":"4","author":"Escombe","year":"2007","journal-title":"PLoS Med"},{"key":"R43-5-20210131","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(07)61636-5","article-title":"Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.","volume":"370","author":"Basu","year":"2007","journal-title":"Lancet"},{"key":"R44-5-20210131","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMoa051908","article-title":"Antiretroviral therapy in a thousand patients with AIDS in Haiti.","volume":"353","author":"Severe","year":"2005","journal-title":"N Engl J Med"},{"key":"R45-5-20210131","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200404090-00006","article-title":"Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.","volume":"18","author":"Coetzee","year":"2004","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e31818ce6c4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:48:53Z","timestamp":1620971333000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200901010-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31818ce6c4","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}